These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 23946262
1. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome. Lee JE, Park JH, Moon PG, Baek MC. Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262 [Abstract] [Full Text] [Related]
2. PUGNAc induces protein ubiquitination in C2C12 myotube cells. Park JH, Lee JE, Moon PG, Baek MC. Cell Biochem Funct; 2015 Dec; 33(8):525-33. PubMed ID: 26531776 [Abstract] [Full Text] [Related]
3. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Park SY, Ryu J, Lee W. Exp Mol Med; 2005 Jun 30; 37(3):220-9. PubMed ID: 16000877 [Abstract] [Full Text] [Related]
4. Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by nonselective inhibition of O-GlcNAcase. Dehennaut V, Lefebvre T. Proteomics; 2013 Oct 30; 13(20):2944-6. PubMed ID: 23983178 [Abstract] [Full Text] [Related]
5. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Vosseller K, Wells L, Lane MD, Hart GW. Proc Natl Acad Sci U S A; 2002 Apr 16; 99(8):5313-8. PubMed ID: 11959983 [Abstract] [Full Text] [Related]
9. Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes. Macauley MS, He Y, Gloster TM, Stubbs KA, Davies GJ, Vocadlo DJ. Chem Biol; 2010 Sep 24; 17(9):937-48. PubMed ID: 20851343 [Abstract] [Full Text] [Related]
10. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells. Mehdy A, Morelle W, Rosnoblet C, Legrand D, Lefebvre T, Duvet S, Foulquier F. J Biochem; 2012 Apr 24; 151(4):439-46. PubMed ID: 22337894 [Abstract] [Full Text] [Related]
11. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells. Sermikli BP, Aydogdu G, Yilmaz E. Mol Biol Rep; 2020 Aug 24; 47(8):5927-5942. PubMed ID: 32691273 [Abstract] [Full Text] [Related]
17. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. Whitworth GE, Macauley MS, Stubbs KA, Dennis RJ, Taylor EJ, Davies GJ, Greig IR, Vocadlo DJ. J Am Chem Soc; 2007 Jan 24; 129(3):635-44. PubMed ID: 17227027 [Abstract] [Full Text] [Related]
19. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Johnson B, Opimba M, Bernier J. Biochim Biophys Acta; 2014 Jan 24; 1840(1):191-8. PubMed ID: 24035784 [Abstract] [Full Text] [Related]
20. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells. Gao Y, Parker GJ, Hart GW. Arch Biochem Biophys; 2000 Nov 15; 383(2):296-302. PubMed ID: 11185566 [Abstract] [Full Text] [Related] Page: [Next] [New Search]